QED Therapeutics
- Teams
- Clinical Development
Clinical Development
About
The Clinical Development team at QED Therapeutics is responsible for designing, implementing, and overseeing clinical trials to evaluate the safety and efficacy of infigratinib for FGFR-driven disorders and achondroplasia. They collaborate closely with cross-functional teams to ensure data integrity, regulatory compliance, and scientific rigor, with the goal of advancing precision medicine therapies from preclinical stages through clinical development and, ultimately, to market approval.
Other teams at QED Therapeutics
View all
The Org
helps you hire
great candidates
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.
It’s free to use - try it out today.